Evaluation of Nucleic Acid Amplification Tests in the Absence of a Perfect Gold-Standard Test: A Review of the Statistical and Epidemiologic Issues
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
During the past 10 years, medical diagnostic testing for sexually transmitted infections (STIs) has changed markedly as a result of the rapid expansion and marketing of nucleic acid amplification tests (NAATs). Among such new DNA/RNA-amplification techniques are the polymerase chain reaction (PCR), the ligase chain reaction (LCR), and the transcription-mediated amplification (TMA) tests. Regrettably, the test evaluation process undergone by these tests has not always been rigorous or scientifically sound. Here, we review the controversy surrounding the statistical evaluation of these NAATs. We also review some of the traditional and recent statistical methods developed to estimate test sensitivity and specificity parameters in the absence of reliable gold-standard tests. In particular, we review the traditional latent class modeling approach that requires the assumption of independence between diagnostic tests conditional on the true disease status, and the more recent procedures that relax the conditional independence assumption. Finally, we apply some of these statistical modeling techniques to real data to estimate the sensitivity and specificity of a NAAT for Chlamydia trachomatis. On the basis of the latent class modeling approach with a pessimistic prior for culture sensitivity, the NAAT specificity estimate was 97.6% and, on the basis of an optimistic prior, the specificity was 95.3%. Similarly, the sensitivity estimates ranged from 88.1% to 89.6%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384
Nierenberg, A. A. (1988) · JAMA · doi:10.1001/jama.1988.03720110061036 · Cited by 6
Cited by
Classification in the Presence of Label Noise: A Survey
Frenay, B., & Verleysen, M. (2014) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2013.2292894 · Cited by 1,777
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Self-citationEvaluation of diagnostic tests when there is no gold standard. A review of methods
Rutjes, A., Reitsma, J., Coomarasamy, A., Khan, K., & Bossuyt, P. (2007) · Health Technology Assessment · doi:10.3310/hta11500 · Cited by 524
Reitsma, J. B., Rutjes, A. W. S., Khan, K. S., Coomarasamy, A., & Bossuyt, P. M. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.02.005 · Cited by 405
2015 European guideline on the management of Chlamydia trachomatis infections
Lanjouw, E., Ouburg, S., de Vries, H., Stary, A., Radcliffe, K., & Unemo, M. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415618837 · Cited by 328
Metadata
- Authors
- Hadgu, A., Dendukuri, N., & Hilden, J.
- Venue
- Epidemiology
- Published
- 2005-09
- Volume
- 16
- Issue
- 5
- Pages
- 604-612
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W2001613191
- Cited by
- 107
- References
- 2
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of Nucleic Acid Amplification Tests in the Absence of a Perfect Gold-Standard Test: A Review of the Statistical and Epidemiologic Issues. https://app.cochat.ai/papers/10.1097/01.ede.0000173042.07579.17
- The paper
- Hadgu, A., Dendukuri, N., & Hilden, J. (2005). Evaluation of Nucleic Acid Amplification Tests in the Absence of a Perfect Gold-Standard Test: A Review of the Statistical and Epidemiologic Issues. Epidemiology. https://doi.org/10.1097/01.ede.0000173042.07579.17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.